BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36362944)

  • 1. Autoimmune Hemolytic Anemia in Inflammatory Bowel Disease-Report of a Case and Review of the Literature.
    Toplicanin A; Toncev L; Matovic Zaric V; Sokic Milutinovic A
    Life (Basel); 2022 Nov; 12(11):. PubMed ID: 36362944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease.
    Vegh Z; Kurti Z; Gonczi L; Golovics PA; Lovasz BD; Szita I; Balogh M; Pandur T; Vavricka SR; Rogler G; Lakatos L; Lakatos PL
    Scand J Gastroenterol; 2016 Jul; 51(7):848-54. PubMed ID: 26880133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coombs-positive autoimmune hemolytic anemia in Crohn's disease.
    Plikat K; Rogler G; Schölmerich J
    Eur J Gastroenterol Hepatol; 2005 Jun; 17(6):661-6. PubMed ID: 15879729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations.
    He R; Zhao S; Cui M; Chen Y; Ma J; Li J; Wang X
    Front Immunol; 2023; 14():1234535. PubMed ID: 37954590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal Relationship of Extraintestinal Manifestations in Inflammatory Bowel Disease.
    Fedor I; Zold E; Barta Z
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients.
    Roth R; Vavricka S; Scharl M; Schreiner P; Safroneeva E; Greuter T; Zeitz J; Misselwitz B; Schoepfer A; Barry MP; Rogler G; Biedermann L;
    United European Gastroenterol J; 2021 Sep; 9(7):773-780. PubMed ID: 34431613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study.
    Lakatos L; Pandur T; David G; Balogh Z; Kuronya P; Tollas A; Lakatos PL
    World J Gastroenterol; 2003 Oct; 9(10):2300-7. PubMed ID: 14562397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M
    Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune cytopenias associated with inflammatory bowel diseases: Insights from a multicenter retrospective cohort.
    Uzzan M; Galicier L; Gornet JM; Oksenhendler E; Fieschi C; Allez M; Bouhnik Y; Kirchgesner J; Boutboul D; Treton X; Gérard L; Mahévas M; Cosnes J; Amiot A
    Dig Liver Dis; 2017 Apr; 49(4):397-404. PubMed ID: 28063954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease.
    Barrie A; Regueiro M
    Inflamm Bowel Dis; 2007 Nov; 13(11):1424-9. PubMed ID: 17567879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated Crohn's Colitis: Is Localization Crucial? Characteristics of Pediatric Patients From the CEDATA-GPGE Registry.
    Elonen L; Wölfle L; de Laffolie J; Posovszky C;
    Front Pediatr; 2022; 10():875938. PubMed ID: 35712614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual case of ulcerative colitis with concurrent extraintestinal manifestations of primary sclerosing cholangitis, thromboembolism, hemolytic anemia, and hemochromatosis.
    Wu CH; Wong JM; Hsieh SC; Yu CL
    J Microbiol Immunol Infect; 2005 Jun; 38(3):224-9. PubMed ID: 15986075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coombs negative autoimmune hemolytic anemia in Crohn's disease.
    Park BS; Park S; Jin K; Kim YM; Park KM; Lee JN; Kamesaki T; Kim YW
    Am J Case Rep; 2014 Dec; 15():550-3. PubMed ID: 25488633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatologic and extraintestinal manifestations of inflammatory bowel diseases.
    Colìa R; Corrado A; Cantatore FP
    Ann Med; 2016 Dec; 48(8):577-585. PubMed ID: 27310096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Extraintestinal Manifestations in Inflammatory Bowel Diseases - Data from the Romanian National Registry.
    Singeap AM; Girleanu I; Diculescu M; Gheorghe L; Ciocîrlan M; Gheorghe C; Costache A; Tanțău A; Zaharie R; Goldis A; Gheonea D; Dobru D; Dumitru E; Prelipcean CC; Gîlcă-Blanariu GE; Moscalu M; Stanciu C; Trifan A
    J Gastrointestin Liver Dis; 2021 Sep; 30(3):346-357. PubMed ID: 34375380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Classical Extraintestinal Manifestations among Inflammatory Bowel Disease Patients in Saudi Arabia: A Single Tertiary Center Experience.
    Alotaibi A; Alhubayshi A; Allehibi A; Almtawa A; Alotaibi N; Alghamdi A; Alrajhi S; Alqutub A; Aleid A; Alamr A; Ibrahim B; Alahmari M; Alhamidi H; Ahmad S; AlBayyat H; Alshaya O; Altannir Y; Alghamdi A
    Saudi J Med Med Sci; 2024; 12(2):169-174. PubMed ID: 38764558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia.
    Juliao-Baños F; Arrubla M; Osorio L; Camargo J; Londoño J; Cáceres C; Carvajal J; Mosquera-Klinger G; Donado J
    Gastroenterol Hepatol; 2021; 44(6):398-404. PubMed ID: 33172691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Lifetime Risk of Intestinal Complications and Extraintestinal Manifestations in Crohn's Disease and Ulcerative Colitis.
    Lichtenstein GR; Shahabi A; Seabury SA; Lakdawalla DN; Espinosa OD; Green S; Brauer M; Baldassano RN
    Gastroenterol Hepatol (N Y); 2022 Jan; 18(1):32-43. PubMed ID: 35505770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.